Trade Negotiations and Economic Security Initiatives Gain Momentum
In a development highlighting the European Union’s strengthened position, the European Commission has propelled its trade negotiations forward, aided by the global tariff war initiated by former US President Trump. The Commission successfully secured a major agreement with the Mercosur nations—Brazil and Argentina—renowned for their vast lithium and copper reserves. Additionally, efforts are underway to mend relations with Australia, a key player in rare earth elements and lithium, following a significant fallout in late 2023, reports 24brussels.
On the economic security front, regulatory progress is somewhat slowing as member states express concerns over granting excessive authority to the EU executive. This year, Maroš Šefčovič, the European Commissioner for Trade and Economic Security, along with his directorate general, underwent a rebranding to emphasize their focus on economic security. As Brussels prepares to introduce a new “economic security doctrine” by late 2025, the effectiveness of this strategy remains to be seen, raising questions about its true intentions versus merely serving as a public relations initiative.
Critical Medicines Act
What VDL said: “[Health Commissioner] Olivér Várhelyi will lead our work on biotechnologies and his first priority will be the Critical Medicines Act.”
How it’s going: Progress is relatively steady with the Critical Medicines Act, as the Health Commissioner successfully pushed the initiative through during the first 100 days of the new Commission mandate. His commitment to meet this self-imposed deadline may potentially overshadow von der Leyen’s leadership in this area.
The proposal has been received fairly well; however, the absence of a thorough impact assessment on this politically sensitive health initiative—designed to reclaim Europe’s drug production from Asian competitors to safeguard the continent’s medicine supply—has drawn criticism from members of the European Parliament and national governments, which could impede further advancement.